ALCC and ALC Related Headlines
Go Back- Exclusive: STAAR Surgical deal fails as shareholder support remains at around 30%
- ISS recommends STAAR Surgical deal, but warns shareholders have reason to object
- STAAR Surgical falls as Yunqi Capital reiterates opposition to merger with Alcon
- Alcon bumps STAAR Surgical bid to $30.75, but Broadwood remains vehemently against
- STAAR Surgical reveals board dissent over amended Alcon deal ahead of vote
- Exclusive: Broadwood says Alcon's earnings reveal STAAR bid came from 'weakness'
- Alcon, Broadwood trade blows in fight for STAAR Surgical's future
- Alcon rejects raised bid for STAAR Surgical as shareholders revolt
- Broadwood moves to oust STAAR Surgical directors over Alcon deal
- Glass Lewis recommends against STAAR–Alcon merger, bolstering Broadwood’s campaign
- Defensive stocks show deep value as cyclicals run hot, UBS says
- Broadwood files definitive proxy, STAAR reaffirms Alcon merger
- STAAR draws no rival bids as Yunqi joins Broadwood against Alcon deal
- Broadwood files preliminary proxy to block STAAR Surgical sale; company responds
- UBS: Time to cut back on cyclicals, favor select defensives
